Vitaspring Biomedical appointed Jing-Zhou Chen as Chief Executive Officer, President, Chief Financial Officer and Secretary and elected Shao-Hsiang Shih as Chairman following Dr. Ssu-Chuan Lai’s resignation from multiple roles.
IndividualDr. Ssu-Chuan LaiJing-Zhou ChenShao-Hsiang ShihRoleChairperson of the Board; Chief Executive Officer; President; Chief Financial Officer; Secretary; Board memberChief Executive Officer; President; Chief Financial Officer; Secretary; Principal executive & financial officerDirector; Chairman of the BoardType of ChangeResignedAppointedElected/appointedEffective DateSept 7, 2026 at 11:58 p.m. PTSept 7, 2026 at 11:57 p.m. PTSept 7, 2026 (elected at 11:56 p.m. PT; appointed Chairman at 11:57 p.m. PT)ReasonNot the result of any disagreement with the Company on operations, policies or practicesNot disclosedNot disclosedReplacement InfoSuccessor officers appointed (Jing-Zhou Chen assumed officer roles)N/AN/ABackground DetailsN/AAge 40; founder & CEO of Dream Born Co., Ltd. since Mar 2025; prior CEO roles at GBT Cloud Kitchen/Hongxi Enterprise Management (2020–2025); co-founder POKE25 (2018–2020); VP Operations at G-Store (2017–2018); earlier engineering roles; B.S. EE; enrolled in Executive MBAAge 54; Director of Administrative Management of Century Publishing since 2020; prior Director of Education Management roles; bachelor's in Statistics; master's in Buddhist Studies; doctoral student in Eastern Humanistic ThoughtBoard/Committee Role ChangesResigned from BoardDesignated principal executive officer, principal financial officer and principal accounting officer; entitled to indemnification (agreement not yet executed)Appointed Chairman; not appointed to any committee; entitled to indemnification (agreement not yet executed)Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.